[HTML] nih.gov

[HTML][HTML] Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer

DP Li, W Li, J Feng, K Chen, M Tao - Oncology research, 2015 - ncbi.nlm.nih.gov
For non-small cell lung cancer (NSCLC) patients at stage IB, adjuvant chemotherapy does
not improve survival. Evidence suggests that dendritic cell (DC)-activated cytokine-induced …
被引用次数：38 相关文章

Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer.

DP Li, W Li, J Feng, K Chen, M Tao - Oncology Research, 2015 - europepmc.org
For non-small cell lung cancer (NSCLC) patients at stage IB, adjuvant chemotherapy does
not improve survival. Evidence suggests that dendritic cell (DC)-activated cytokine-induced …

Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer

DP Li, W Li, J Feng, K Chen, M Tao - Oncology research, 2015 - pubmed.ncbi.nlm.nih.gov
For non-small cell lung cancer (NSCLC) patients at stage IB, adjuvant chemotherapy does
not improve survival. Evidence suggests that dendritic cell (DC)-activated cytokine-induced …